Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Multiple Sclerosis

This study has been completed.
Provinciale Hogeschool Limburg
Information provided by (Responsible Party):
Koen Cuypers, Hasselt University Identifier:
First received: January 19, 2011
Last updated: September 4, 2012
Last verified: September 2012
In this study the researchers want to investigate the effects of long-term transcutaneous electrical nerve stimulation on the cortical excitability of persons with multiple sclerosis.

Condition Intervention
Multiple Sclerosis
Device: Transcutaneous electrical nerve stimulation

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Hasselt University:

Primary Outcome Measures:
  • Change in cortical excitability [ Time Frame: Baseline, immediately after and 3 weeks after the intervention ]
    Cortical excitability will be assessed using transcranial magnetic stimulation (TMS)

Estimated Enrollment: 20
Study Start Date: January 2011
Study Completion Date: June 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: TENS
Transcutaneous electrical nerve stimulation will be applied on the impaired hand
Device: Transcutaneous electrical nerve stimulation
3 weeks, 5 times a week, 60 minutes a day.
Sham Comparator: Sham TENS
Sham TENS will be applied to the impaired hand
Device: Transcutaneous electrical nerve stimulation
3 weeks, 5 times a week, 60 minutes a day.


Ages Eligible for Study:   18 Years to 68 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Expanded Disability Status Scale (EDSS) scores between 2 and 6.5
  • Stable MS (no relapse during the last 3 months before study onset)
  • sensory impairment
  • age: between 18 and 68 years old

Exclusion Criteria:

- Patients with other pathologies associated with peripheral and/or central sensory dysfunction or under psychotropic or antiepileptic medication

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01280539

Hasselt University (BIOMED)
Diepenbeek, Limburg, Belgium, 3590
Sponsors and Collaborators
Hasselt University
Provinciale Hogeschool Limburg
  More Information

Responsible Party: Koen Cuypers, Drs, Hasselt University Identifier: NCT01280539     History of Changes
Other Study ID Numbers: MECU2012-002
Study First Received: January 19, 2011
Last Updated: September 4, 2012

Keywords provided by Hasselt University:
Multiple Sclerosis
Transcutaneous electrical nerve stimulation
Cortical Excitability

Additional relevant MeSH terms:
Multiple Sclerosis
Pathologic Processes
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases processed this record on May 25, 2017